Agathe Michel-De-Cazotte
PartnerCarpmaels & RansfordAndreas Robinson
Senior Counsel Intellectual Property & LitigationAmgenAndrew Hutchinson
PartnerSimmons & SimmonsAntje Brambrink
CounselFinneganDr. Antje Brambrink is qualified and admitted as an attorney at law in Germany. She advises and represents clients in complex patent disputes on all IP-related matters, often at the interface of antitrust and regulatory laws. Her expertise covers various fields of technology with a focus on pharmaceuticals, biotechnology, med-tech, as well as renewable energies and high-tech. Our clients appreciate Antje’s deep understanding of the life sciences sector based on her dual qualification as a licensed dentist.
As a patent litigator, Antje represents clients in infringement, preliminary injunction and inspection proceedings before German district and appeal courts as well as in nullity and compulsory license proceedings at the German Federal Patent Court and the Federal Supreme Court.
In addition to her work as a litigator, Antje advises clients strategically on all issues relating to intellectual property rights (patents, utility models, supplementary protection certificates), such as contracts for the licensing and transfer of rights also in connection with international transactions or the newly established Unified Patent Court (UPC). She has extensive experience in the European coordination of multinational patent disputes.
Prior to joining Finnegan, Antje practiced patent litigation for several years in the patent litigation teams of two international law firms seated in Germany. Antje’s medical and scientific background is of great benefit in advising clients from the life sciences sector. Renowned pharmaceutical, biotechnology and medical devices companies regularly seek her advice. She also advises in the field of renewable energies and in the enforcement of standard-essential patents.
Aoife Murphy
PartnerDLA PiperArjan Reijns
Legal Director AmsterdamPinsent MasonsArvid van Oorschot
PartnerVondstBenjamin May
PartnerAramisBenjamin May was admitted to practice law in 2000 and further admitted to the panel of “Intellectual Property specialists” with the Bar Association. Practice head of IP at Aramis, Benjamin specializes in cross-border patent litigation with a focus on pharmaceuticals, medical devices and biotechs. The 7 attorneys of the IP team are all internationally trained and address a wide range of patent law matters (e.g. invalidity strategies, infringement, launching at risk, preliminary injunctions, licensing, R&D and consortium agreements). In 2023 the team was ranked amongst the leading patent litigation practices in France, and Benjamin as “leading individual” (Legal 500).
Brian Goldberg
CounselDechertBrian M. Goldberg is a Counsel in Dechert LLP’s intellectual property practice with a focus on life sciences patent litigation. Mr. Goldberg has successfully litigated patent cases through bench and jury trials, as well as parallel PTAB proceedings, with vast experience litigating Hatch-Waxman Act ANDA infringement actions. Mr. Goldberg has extensive first-hand experience applying the doctrine of equivalents in patent litigations involving small molecule and biologic pharmaceutical products. Mr. Goldberg’s neuroscience background and deep understanding of the statutory and regulatory framework of the Hatch-Waxman Act provides him invaluable insight in litigating cases to achieve successful outcomes for his clients.
Brian O'Moore
Honourable JudgeIrish High CourtCecile Goy
PartnerAramis LawCécile Goy is a member of the Paris Bar focusing on international patent litigation, in particular in the life sciences sector. Before joining Aramis, Cécile worked with an international IP boutique and in-house in the legal department of a car manufacturer. Cécile has also completed an internship at the IP section of the Paris Court of Appeal. Cécile is the author of several articles, including on medical devices and digital therapeutics.
Charles Collins-Chase
PartnerFinneganCharles Collins-Chase focuses on district court patent litigation and appeals before the U.S. Court of Appeals for the Federal Circuit, where he served as a clerk. He uses his chemical engineering background to help clients protect innovations in pharmaceuticals and biotechnology, energy and renewables, and chemical products. He has assisted numerous clients in Hatch-Waxman (ANDA) litigation. Charles has handled district court litigations at every stage, from pre-litigation through discovery, dispositive motions, and trial. He particularly enjoys writing briefs and motions.
Charles has extensive experience at the Federal Circuit, where he has argued cases and assisted clients in over two dozen appeals from district courts and the Patent Trial and Appeal Board (PTAB). He has particular experience in appeals involving patent eligibility under 35 U.S.C. § 101. Charles lectures on and has published in several legal and industry media outlets on strategic IP considerations for protecting AI innovations in the pharmaceutical industry.
Before law school, Charles completed an M.Phil. in engineering for sustainable development at the University of Cambridge, where he researched the feasibility of community-scale biodiesel production using a novel reactor system. His undergraduate thesis research involved synthesizing and characterizing thermosetting polymers made from soybean oil and other renewable resources.
Charles also devotes substantial time to pro bono matters and leads the firm’s pro bono committee. He argues before the Federal Circuit on behalf of veterans seeking service-connected disability benefits. He successfully represented a client seeking Social Security disability benefits, writing the briefs and arguing at a hearing before an administrative law judge.
He holds a J.D. (cum laude) from University of Pennsylvania Law School.
Chris Buntel
Co-Founder & CIPOTangiblyChris Buntel is a US intellectual property attorney with over 20 years experience connecting innovation and intellectual property law. He is a co-founder and the CIPO of Tangibly. Chris is passionate about trade secrets – the “next big thing” in intellectual property evolution. While other forms of intellectual property have been well supported for years, people are just now realizing the huge need for trade secret management tools and education. He has a Ph.D. in Organic Chemistry from Stanford University, and J.D. in Law from University of Houston.
Christine Kanz
PartnerHoyng Rokh MonegierChristopher Freeth
Principal AssociateGowling WLGClemens Heusch
Head of Global Disputes and ResolutionNokiaConrad Eckhardt
Vice President IPBiotronikConrad practices in the IP field for more than 20 years and gained experience across various industries. Having started with Consumer Products at Procter & Gamble he moved on to Pharmaceuticals at Boehringer Ingelheim and is now active in the medical device field, first as Chief IP Counsel at Leica Biosystems and currently as Chief IP Counsel at Biotronik. Conrad is a European Patent Attorney and a European Patent Litigator and has patent litigation experience in Germany, the USA and China.